Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)
收藏NIAID Data Ecosystem2026-03-07 收录
官方服务：
资源简介：
The purpose of this protocol is to allow continued treatment with conatumumab and/or ganitumab, with or without chemotherapy, to participants who completed a separate Amgen-sponsored conatumumab or ganitumab study without disease progression whose previous studies were closed.
创建时间：
2011-03-15
